A detailed history of Kestra Advisory Services, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 241,519 shares of VYGR stock, worth $1.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
241,519
Previous 256,449 5.82%
Holding current value
$1.41 Million
Previous $2.39 Million 19.98%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.42 - $10.54 $110,780 - $157,362
-14,930 Reduced 5.82%
241,519 $1.91 Million
Q1 2024

May 15, 2024

BUY
$7.15 - $10.84 $288,631 - $437,589
40,368 Added 18.68%
256,449 $2.39 Million
Q4 2023

Feb 14, 2024

BUY
$6.28 - $8.81 $562,675 - $789,358
89,598 Added 70.84%
216,081 $1.82 Million
Q3 2023

Nov 09, 2023

BUY
$7.55 - $11.25 $954,946 - $1.42 Million
126,483 New
126,483 $980,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $226M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.